Cimetidine 100 mg proposed for switch in Canada, could be approved by April.
This article was originally published in The Tan Sheet
Executive Summary
CANADIAN CIMETIDINE 100 MG Rx-TO-OTC SWITCH PROPOSED by Health Canada in the Nov. 16 issue of Canada Gazette, the country's Federal Register equivalent. "This deregulatory initiative will permit cimetidine tablets to be available without a prescription," the notice states. The proposal is open to public comment for 30 days following publication. There is no marketing exclusivity granted for switch applications in Canada.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning